UROMEMS is an innovative company focuses on designing, developing and commercializing active implantable medical devices for the severe urinary incontinence treatment. Company’s ambition is to improve current surgical treatments for helping as many patients as possible, particularly by reducing associated side effects and difficulties faced by healthcare professionals.
UROMEMS’s mission is to offer implantable solutions that are :
– easy to use for the patient in order to give them back a real autonomy and a normal social life,
– easy to operate for healthcare professionals,
– more effective, less invasive than current surgical techniques.
Company’s ambition is to revolutionize the treatment for severe urinary incontinence using the latest technological advances in the field of embedded systems and micro-technologies for the development of its implantable products
Members directory
UROMEMS is an innovative company focuses on designing, developing and commercializing active implantable medical devices for the severe urinary incontinence treatment. Company’s ambition is to improve current surgical treatments for helping as many patients as possible, particularly by reducing associated side effects and difficulties faced by healthcare professionals.
UROMEMS’s mission is to offer implantable solutions that are :
– easy to use for the patient in order to give them back a real autonomy and a normal social life,
– easy to operate for healthcare professionals,
– more effective, less invasive than current surgical techniques.
Company’s ambition is to revolutionize the treatment for severe urinary incontinence using the latest technological advances in the field of embedded systems and micro-technologies for the development of its implantable products
UROMEMS
32 rue Gustave Eiffel
38000 GRENOBLE - FRANCE
Date of creation : 2011
Number of employees : 11
www.uromems.com
Director
Hamid LAMRAOUI
+33 (0)4 80 42 02 41
hamid.lamraoui@uromems.com
Contact
Myriam LECLERC
+33 (0)4 80 42 02 40
myriam.leclerc@uromems.com
UroMems Raises €16 Million to Advance Development of Electronic Artificial Urinary Sphincter (eAUS) for Stress Urinary Incontinence
UROMEMS closes €14M financing to develop its smart artificial urinary sphincter to market